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Abstract Thunderclap headache (TCH) is an excruciat-
ing headache characterized by a very sudden onset. Rec-
ognition and accurate diagnosis of TCH are important in
order to rule out the various, serious underlying brain
disorders that, in a high percentage of cases, are the real
cause of the headache. Primary TCH, which may recur
intermittently and generally has a spontaneous, benign
evolution, can thus be diagnosed only when all other
potential underlying causes have been excluded through
accurate diagnostic work up. In this review, we focus on
the management of TCH, paying particular attention to the
diagnostic work up and treatment of the condition.
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The nosography of TCH
Fisher [1] used the expression ‘‘crash migraines’’ to
describe acute, high-intensity headaches similar to those
caused by ruptured saccular aneurysms, but with normal
lumbar puncture and angiography. Day and Raskin [2]
coined the term ‘‘thunderclap headache’’ to refer to a
similar type of headache occurring in a patient who had
three severe, acute episodes of headache within 1 week.
The brain CT scan and the cerebrospinal ﬂuid (CSF)
examination were normal in this patient, while cerebral
angiography showed diffuse, multifocal, and segmental
cerebral vasospasm with a saccular aneurysm at the origin
of the right posterior cerebral artery. No evidence of
haemorrhage was found during surgical removal of the
aneurysm. The authors concluded that unruptured intra-
cranial aneurysms can present with ‘‘thunderclap head-
ache’’ and that angiography is necessary in patients
presenting ‘‘headache episodes with the thunderclap pro-
ﬁle’’, even when CT and CSF are normal.
Thunderclap headache (TCH) is a severe and headache
of the explosive type that appears suddenly, like a ‘‘clap of
thunder’’, with peak intensity of the pain occurring at onset
(usually within 30 s).
The International Classiﬁcation of Headache Disorders,
second edition (ICHD-II, 2004) categorizes headaches into
primary and secondary forms based on the absence or
presence of intracranial lesions. This classiﬁcation has
included TCH in Group IV—other primary headaches
(code 4.6) (Table 1) and has proposed precise diagnostic
criteria [3].
The nosography of most headaches included in group IV
is not immediate. Although some of them are simply
identiﬁed according to their trigger—i.e. cough headache,
sexual headache, exertional headache—it is mandatory to
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DOI 10.1007/s10194-011-0302-zaccurately rule out any possible organic cause (that is to
exclude a possible secondary origin) when a patient with
one of these provoked headaches is seen for the ﬁrst time.
Indeed a recent publication [4] shows that 18 of 30 patients
with sexual headaches with an abrupt and severe head-
ache—which was similar to TCH in most cases—had
reversible cerebral vasoconstriction syndrome (RCVS)
(code 6.7.3 in ICHD-II).
Thunderclap headache is a rare type of headache with an
incidence of 43 cases per 100,000 adults per year [4].
Primary TCH closely mimics secondary forms of TCH and
therefore appropriate instrumental investigations are abso-
lutely mandatory to rule out possible organic causes [5].
The close similarity between primary and secondary TCH
has led to the hypothesis that the primary form may, in
some cases, actually be a wrong diagnosis resulting from
the incapacity of instrumental diagnostics to identify the
organic cause [6]; for this reason, the alternative term
‘‘thunderclap headache of undeﬁned origin’’ has also been
proposed [7].
Some authors [8] showed that patients with recurrent
TCH can be divided in two groups based on the result of
MRA: those with diffuse vasospasm and those without any
(visible) vasospasm. However, both groups had similar
clinical featuresand bothshowedthe samerate ofischaemic
complications[6–7%ofposteriorreversibleencephalopathy
syndromes (PRES) and of ischaemic stroke]. These authors
therefore suggested that ‘‘primary TCH’’ and RCVS may be
partofthesamespectrum.Ducrosetal.[9]showedthat21%
of 67 patients with a proven RCVS had an initial normal
MRA and they would have been classiﬁed as ‘‘primary
TCH’’ in the absence of a second MRA repeated after a few
days later or of a conventional angiogram. Furthermore,
other authors showed that the arterial abnormalities of
RCVS, as assessed by non invasive tools, increase several
daysafterTCHonset.Indeedmeanﬂowvelocitiesofmiddle
cerebralartery(MCA)measuredbytranscranialDopplerare
maximal at 18–25 days after TCH onset [10], and MRA
vasoconstriction scores are maximal 16 ± 10 days after
headacheonset,closetoheadacheresolutionat16 ± 9 days
[11].
Therefore, it is possible that some of ‘‘primary’’ TCHs
are actually forms of RCVS whose arterial abnormalities
went undetected by neuroimaging. The clinical and diag-
nostic overlapping is also reﬂected in the pathophysiolog-
ical ﬁeld where the proposed mechanisms for the so-called
primary TCH are vasospasm and autonomic dysfunction,
which are also thought to underline RCVS. A certain
degree of overlapping between TCH and RCVS also exists
as regards treatment because nimodipine shows beneﬁcial
effect both in the presence and in the absence of vaso-
spasm. RCVS is a vascular disorder that is frequently, but
by no means always, benign. Stroke occurs in 5–15% of the
prospective series [4, 9] and death has also been reported.
Thus, the clinical spectrum of RCVS is large and it ranges
from isolated recurrent and self-limiting TCH to life-
threatening forms. Severe forms of RCVS were previously
misdiagnosed as ‘‘benign’’ forms of primary angiitis of the
central nervous system (PACNS), with good evolution and
prognosis, and normalization of arterial irregularities after
a short course of steroids. Calabrese et al. [12] ﬁrst pro-
posed that these patients had benign angiitis of the central
nervous system (BACNS) and later on recognized that
BACNS was equivalent to RCVS.
True primary TCH has a relatively benign prognosis.
Although headache can recur within the ﬁrst week after
onset, it generally does not recur regularly over subsequent
weeks or months [3]. As regards the pathophysiology of
primary TCH, the sympathetic nervous system probably
plays an important role. The proximal portions of the large
intracranial arteries are indeed innervated by neuropeptide
Y and noradrenaline-containing sympathetic afferents,
which modulate vascular tone [13, 14]. It has been sug-
gested that the head pain in TCH may be due to acute
vasoconstriction or alterations in vascular tone secondary
to heightened sympathetic tone, and indeed there exist
experimental and clinical data supporting a pivotal role of
the sympathetic nervous system (e.g. TCH attacks associ-
ated with hypertension or preceded by events associated
with elevated sympathetic tone, such as episodes of anger,
sexual intercourse, and exertion) [15, 16]. Vasoconstriction
per se does not seem to be the cause of pain, since in the
cases of TCH with RCVS it is a long-lasting phenomenon,
which may persist for hours up or weeks, even when
headache has already disappeared [17]. It seems more
likely that pain in TCH results from a combination of
vasoconstriction with systemic or local autonomic chan-
ges. In patients with sexual headache resembling TCH
associated with RCVS, additional factors that may con-
tribute to pain induction are possibly represented by the
psychological stress associated with sexual arousal and by
Table 1
4. Other primary headaches
4.1 Primary stabbing headache
4.2 Primary cough headache
4.3 Primary exertional headache
4.4 Primary headache associated with sexual activity
4.4.1 Preorgasmic headache
4.4.2 Orgasmic headache
4.5 Hypnic headache
4.6 Primary thunderclap headache
4.7 Hemicrania continua
4.8 New daily-persistent headache (NDPH)
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123the activation of systemic autonomic reﬂexes, which result
in increased blood pressure and heart rate [18].
As regards the pathophysiology of the arterial spasm,
several factors—encompassing mechanical stimulation,
biochemical mediators, and neurogenic events—may be
invoked. Vasoactive substances, i.e. ergotamine, amphet-
amine, cocaine may trigger it. Alternatively, the formation
of circulating metabolites (i.e. during eclampsia or pheo-
chromocytoma) or the exposure to toxins (i.e. angiographic
contrast material) are all possible causes for vasospasm
[19].
The diagnostic work-up
It is essential to remember that a diagnosis of primary or
secondary TCH can be made only when exhaustive instru-
mental investigations have been performed. To manage a
patient with TCH correctly, the clinician must be aware of
all the organic disorders that can act as a causative factors.
These are, ﬁrst of all, subarachnoid haemorrhage (SAH),
but also cerebral venous sinus thrombosis, carotid artery
dissection, hypertensive encephalopathy, spontaneous ret-
roclival haematoma, sentinel headache, ischaemic stroke,
pituitary apoplexy, spontaneous intracranial hypotension,
colloid cyst of the third ventricle, intracranial infection,
PACNS. It is also worth noting that a headache with clinical
features of TCH has been described in conditions not
associated with a structural abnormality, such as bathing
headache, primary cough, sexual and exertional headaches,
and RCVS. Recently, some authors have proposed diag-
nostic criteria for TCH attributed to idiopathic reversible
cerebral vasoconstriction (THARCV) syndrome based on
the clinical and radiological features [18].
Table 2 shows the diagnostic work up and the main
criteria for the differential diagnosis of primary TCH ver-
sus other disorders that can cause/be associated with TCHs
[12–88].
While deﬁning the diagnosis, TCH must always be
managed as a medical emergency in order to avoid
potentially catastrophic consequences that can occur with
secondary TCH. The initial diagnostic assessment must be
aimed at ruling out SAH. Non-contrast brain CT is the ﬁrst
examination in this assessment, to be performed within the
ﬁrst 12 h after the onset of the headache, preferably using
third-generation CT scanners that have a speciﬁcity of 98%
and a sensitivity close to 100% [25]. The sensitivity of CT
for the detection of SAH declines with increasing time
from haemorrhage onset, falling to 86% on day one, 76%
after 2 days, and 58% after 5 days [84]. Therefore,
although the sensitivity of CT scan in detecting SAH is
very high in the early phase, if we consider also the pos-
sibility of human error, which, in the case of SAH, may be
fatal, we recommend to perform lumbar puncture even in
the presence of a normal brain CT. CSF assessment is
deﬁnitely mandatory in patients who come to clinical
attention 12 h after TCH onset and have normal or non-
diagnostic brain CT scans. Blood and CSF work up (rou-
tine cell counts, measurement of protein, glucose, opening
pressure, and inspection for xanthochromia) should be
performed. Because visual inspection for xanthochromia is
associated with a high rate of false-negative interpretations,
spectrophotometry should be performed when available.
Spectrophotometry also helps to overcome the problem of
false-positives; analysis for bilirubin by spectrophotometry
has a sensitivity close to 100% when lumbar puncture is
performed between 12 h and 2 weeks after SAH [27].
Magnetic resonance imaging (MRI), which can detect
many of the possible causes of secondary TCH, should be
performed in all TCH patients with normal or non-diag-
nostic CT scans and CSF analysis. In most cases, magnetic
resonance studies should include cerebral MRI, magnetic
resonance angiography, magnetic resonance venography
and, if necessary, MRI of the cervical arteries using the fat
saturation technique. CT angiography can be used instead
of magnetic resonance angiography for the diagnosis of an
intracranial aneurysm. Evidence suggests that conventional
cerebral angiography is not necessary in the assessment of
patients with TCH, normal neurological examinations, and
normal CT and lumbar puncture [32].
Some authors believe that conventional cerebral angi-
ography should be avoided, since the contrast medium
could enhance the vasospasm and this, in turn, would
increase the chance of a stroke or even cause further
deterioration of a critical neurological condition [18].
However, since there is no adequate evidence to conclude
that conventional angiography can result in worsening
vasoconstriction, in highly selected cases, when the clinical
suspicion of intracranial aneurysm remains high despite
normal or non-diagnostic CT, lumbar puncture, and MRI
studies, conventional angiography has to be considered.
The treatment
The following indications have been derived from the
information collected from a systematic analysis of the
international literature. We conducted a literature search
covering the period 1932–2010, employing available elec-
tronic databases (National Library of Medicine, National
Institute of Health, Embase) with the following medical
search terms: ‘‘thunderclap’’, ‘‘cough’’, ‘‘exertional’’,
‘‘exercise’’, ‘‘orgasmic’’, ‘‘sex’’, or ‘‘abrupt’’ in association
with ‘‘headache’’. Whenever available, chapters of book
were also consulted and considered. Unfortunately, the
literature contains very few reports on the treatment of
J Headache Pain (2011) 12:251–258 253
123Table 2 Differential diagnosis of TCH
Disease Neurological symptoms/signs Precipitating factors Comments
Subarachnoid haemorrhage
(SAH) [19–32]
Headache Physical exertion About 70% of pts with SAH
present with headache alone Loss of consciousness Sexual intercourse
Focal neurological symptoms
Cerebral venous sinus
thrombosis (CVST) [33–42]
Headache Puerperium 15–30% of pts present with
isolated headache that can
worsen in the recumbent
position
Altered consciousness Dehydration
Focal neurological symptoms/
signs
Cancer
Cervical artery dissection
(CAD) [3, 43–45]
Headache Head and neck
injury
Generally headache is
ipsilateral to the CAD Amaurosis fugax
Horner’s syndrome
Focal neurological symptoms/
signs
Acute hypertensive crisis
(AHC) [46–51]
Headache Hypertensive crisis Headache occurs in about 20%
of pts with AHC Altered mental status
Seizures
Focal neurological symptoms/
signs
Spontaneous retroclival
hematoma (SRH) [52, 53]
Headache None SRH is very rare
Mild nuchal rigidity
Oculomotor nerve palsy
Upper limb paresis
Sentinel headache (SH) [54] Headache Physical exertion SH is present in 10–40% of pts
with SAH Focal neurological symptoms/
signs generally absent
Sexual intercourse
Ischaemic stroke (IS) [55–58] Headache None Headache is more common
with large IS Focal neurological symptoms/
signs
Pituitary apoplexy (PA)
[22, 58–60]
Headache Pregnancy PA commonly occurs in pts
with no known pituitary
tumour history
Visual disturbances
Spontaneous intracranial
hypotension (SIH) [61–64]
Orthostatic headache Valsalva manoeuvre TCH is present, at onset, in
about 15% of pts with SIH Hearing disturbances
Mild nuchal rigidity
Colloid cysts of third ventricle
[73–75]
Headache None Headache can be relieved by
recumbency Loss of consciousness
Seizures
Coma
Reversible cerebral
vasoconstriction syndrome
(RCVS) [8, 69–73]
Headache Postpartum RCVS is spontaneous in about
30% of cases Focal neurological symptoms/
signs
Sexual intercourse
Drugs exposure (see
bottom of table)
Prognosis is uncertain, but
most pts do well
Blood products (see
bottom of table)
Head trauma
Neurosurgical
procedures
Benign hot bath-related
headache [74–78]
Headache Hot bath Headache disappears
spontaneously after a period
of 2 weeks to 3 months
Normal neurological
examination
Hot shower
Primary cough, Headache Cough These headache forms are
254 J Headache Pain (2011) 12:251–258
123primary TCH and those that are available are mostly rep-
resented by single case reports. Primary TCH generally
responds poorly to analgesics. In one report, a woman with
an apparent primary TCH had frequent recurrences of the
headache until she reached (by day 14) a therapeutic dosage
of gabapentin 600 mg three times a day [85]. The exact
mechanism of action through which gabapentin decreases
headache pain is not known, although multiple mechanisms
might be involved. Gabapentin enhances GABA-mediated
inhibition, inhibits GABA metabolism and modulates
L-type calcium channels by binding to their a2d subunit
[86].
Nimodipine showed beneﬁcial effect both in the pres-
ence and in the absence of vasospasm. IV nimodipine and
magnesium were administered to a 63-year-old woman
with TCH and vasospasm; a posterior ischaemic infarct had
occurred before infusion [87]. The patient’s headaches
resolved within hours, and transcranial Doppler sonogra-
phy revealed normalized mean cerebral blood ﬂow veloc-
ity, suggesting relief of the vasospasm. The mean cerebral
blood ﬂow velocity increased again when oral nifedipine,
another calcium channel blocker, was used in place of
nimodipine. Nimodipine infusion effectively stopped TCH
in another woman, aged 58 years, who had vasospasm and
posterior ischaemic infarct. Serial MR angiography showed
marked improvement of vasospasm within 2 days [88].
Lu et al. [89] described 11 patients with primary TCH
(nine without vasospasm and two with vasospasm) treated
with nimodipine. In eight of the nine patients without
vasospasm, TCH stopped within 24 h of oral nimodipine
administration; the other patient had one further attack
2 days later. The highest dosage of nimodipine was 30 mg
every 4 h in four patients, 45 mg every 4 h in one, and
60 mg every 4 h in four. No hypotension or other adverse
effects were noted. The treatment lasted 3–4 weeks with
gradual tapering. In the two patients with arterial vaso-
spasm, oral nimodipine was only temporarily effective and
TCH recurred. When IV nimodipine was given instead,
TCH subsided in 6 h without recurrence. In one of the
patients, the dose infused was 2 mg/h; in the other, it was
lower (0.5–1 mg/h) because of the appearance of nimodi-
pine-induced hypotension. The IV route was switched to
oral when MR angiography or transcranial Doppler
sonography no longer showed evidence of vasospasm. The
duration of IV nimodipine treatment was variable, ranging
from 5 to 10 days. No patient reported a relapse of TCH
during a mean 6-month follow-up (range 1–19 months)
after nimodipine discontinuation. These reports suggest
that IV nimodipine is the drug of choice for primary TCH
with cerebral vasospasm, whereas oral nimodipine can be
used in patients without vasospasm, although the optimal
dose and time window remain to be determined. It is
noteworthy that the patients with TCH associated with
vasospasm described in the above reports [87–89], the
correct diagnosis should be RCVS rather than TCH, while
only the nine without vasospasm described by Lu et al. [89]
can technically be classiﬁed as having primary TCH,
although with a certain degree of approximation since one
cannot exclude a RCVS without visible vasoconstriction at
the time of angiogram. Therefore, these nine subjects can
be regarded either as ‘‘probable RCVS’’ or ‘‘probable pri-
mary TCH’’.
Following this line of reasoning, if we consider that, in
some cases, RVCS may be missed by MRA because of
timing issues, it seems wise to avoid tricyclic antidepres-
sants (e.g. amitriptyline) and propranolol because they may
facilitate the development of vasoconstriction as suggested
by Valenca et al. [18]. In analogy, vasoconstrictor medi-
cations, such as ergots and triptans, should be contraindi-
cate during the treatment of headache of patients with
Table 2 continued
Disease Neurological symptoms/signs Precipitating factors Comments
sexual and exertional
headaches [3, 79]
Normal neurological
examination
Physical exertion an exclusion diagnosis
Sexual activity
Primary angiitis of the central
nervous system (PACNS)
[72, 80–83]
Headache None Headache is the most common
presenting symptom Seizures
Behavioural disturbances
Focal neurological symptoms/
signs
Primary thunderclap headache
(TCH) [3, 12–15, 24, 26,
84–89]
Headache None TCH is an exclusion diagnosis
and has a relatively benign
prognosis
Normal neurological
examination
Drugs exposure phenylpropanolamine, ergotamine tartrate, methergine, bromocryptine, lisuride, tricyclic antidepressants, selective serotonin
reuptake inhibitors, sumatriptan, isometheptine, cocaine, ecstasy, amphetamine derivatives, marijuana, lysergic acid diethylamide, tacrolimus
(FK-506), cyclophosphamide
Blood products erythropoietin, intravenous immune globulin, and red blood cell transfusions
J Headache Pain (2011) 12:251–258 255
123potential cerebral vasoconstriction syndromes, at least in
the acute phase and until ongoing or impending RVCS has
been ruled out.
Conclusions
All patients with TCH proﬁles must be assessed urgently
and thoroughly in order to consider and rule out all the
possible organic causes. After the exclusion of all sec-
ondary causes, including RCVS, there are very few patients
left with true ‘‘primary TCH’’.
The data gathered in recent years suggest that, in order
to avoid false primary TCHs, it is appropriate to perform
neuroimaging studies (brain MRI angiography or CT
angiography) 3–4 weeks after the onset of all cases of TCH
with negative instrumental ﬁndings during the acute phase
in order to exclude the presence of delayed vasospasm [10,
11] and therefore identify the true primary TCHs.
Once the diagnosis has been deﬁned with certainty,
secondary forms of TCH must be managed through treat-
ment of the underlying brain disorder. For primary TCH, as
well as for forms associated with RCVS, the therapeutic
options are restricted to nimodipine, intravenously or orally
administered, although gabapentin was reported effective
in one case of primary TCH.
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